Oak Thistle LLC Boosts Stake in Zimmer Biomet

Medical device company sees increased institutional investment

Apr. 8, 2026 at 11:52am

Got story updates? Submit your updates here. ›

Oak Thistle LLC, an investment management firm, has increased its stake in Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a leading global medical device company focused on musculoskeletal healthcare. According to a recent 13F filing, Oak Thistle grew its position in Zimmer Biomet by 78.8% during the fourth quarter.

Why it matters

Zimmer Biomet is a major player in the orthopedic and dental implant market, and increased institutional investment in the company signals confidence in its long-term growth prospects. This news comes as the medical device industry navigates evolving regulatory environments and consumer trends.

The details

Oak Thistle LLC now owns 29,314 shares of Zimmer Biomet's stock, worth approximately $2.636 million as of the end of the reporting period. The firm added 12,921 shares to its position during the fourth quarter. Zimmer Biomet's product offerings span joint replacement systems, trauma and extremities implants, spine and dental solutions, and sports medicine devices.

  • Oak Thistle LLC increased its stake in Zimmer Biomet during the fourth quarter of 2025.

The players

Oak Thistle LLC

An investment management firm that has increased its stake in Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

The takeaway

The increased investment in Zimmer Biomet by Oak Thistle LLC suggests that institutional investors see long-term growth potential in the medical device company, which continues to navigate a dynamic industry landscape.